Provided by Tiger Trade Technology Pte. Ltd.

CMS Energy Corp

63.64
+0.56000.89%
Post-market: 63.650.0100+0.02%19:49 EDT
Volume:5.79M
Turnover:366.70M
Market Cap:19.96B
PE:19.11
High:63.71
Open:62.96
Low:62.55
Close:63.08
52wk High:80.36
52wk Low:62.29
Shares:313.58M
Float Shares:311.85M
Volume Ratio:1.18
T/O Rate:1.86%
Dividend:2.23
Dividend Rate:3.50%
EPS(TTM):3.33
EPS(LYR):3.52
ROE:9.16%
ROA:2.97%
PB:2.09
PE(LYR):18.05

Loading ...

Jefferies Adjusts Price Target on CMS Energy to $78 From $74, Maintains Hold Rating

MT Newswires Live
·
Jul 16

CMS Receives Clinical Trial Approval for Its Novel Complement Factor B Inhibitor in Age-Related Macular Degeneration

Stock News
·
Jul 15

Barclays Adjusts CMS Energy Price Target to $81 From $79, Maintains Overweight Rating

MT Newswires Live
·
Jul 14

CMS Energy is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

CMS Energy Corporation : Barclays Raises Target Price to $81 from $79

THOMSON REUTERS
·
Jul 14

Aroa Biosurgery Says Randomized Controlled Trial for Symphony Product Meets Primary Endpoint

MT Newswires Live
·
Jul 14

Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates

TIPRANKS
·
Jul 14

Arhaus Names Meijer CEO Rick Keyes to Board as Independent Director

Reuters
·
Jul 14

InSilico Medicine, CMS Expand Drug Development Partnership

MT Newswires Live
·
Jul 13

Truist Securities Adjusts CMS Energy Price Target to $85 From $83

MT Newswires Live
·
Jul 10

CMS Energy's Q2 Earnings Likely Weighed Down by Unfavorable Weather, UBS Securities Says

MT Newswires Live
·
Jul 09

Consumers Energy Tops Michigan Land Restoration Goal Early, Reaches 6,700 Acres

Reuters
·
Jul 09

Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

GlobeNewswire
·
Jul 08

4 ETF Winners of June Likely to Gain in July

zacks
·
Jul 08

Nyxoah Rides U.S. Momentum and CMS Boost in Strong Q2 Preliminary Results

TIPRANKS
·
Jul 08

Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus

Simply Wall St.
·
Jul 08

CMS Energy to Report Q2 2026 Results, Issue Outlook in Webcast

Reuters
·
Jul 08

Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration

GlobeNewswire
·
Jul 07

Orthofix says CMS revised guidance that withdrew bone growth stimulator changes

TIPRANKS
·
Jul 06

Press Release: East West Manufacturing(tm) Acquires Vexos, Expanding Engineering Expertise and Global Manufacturing Capabilities

Dow Jones
·
Jul 03